Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy

Journal of Heart and Lung Transplantation

Volumn 29, Issue 3, 2010, Pages 299-305

  Uçkay, Ilker ^a   Gasche Soccal, Paola M ^a   Kaiser, Laurent ^a   Stern, Richard ^a   Mazza Stalder, Jesica ^a,b   Aubert, John David ^b   van Delden, Christian ^a,c  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

infection; lung transplantation; RSV; virus

Indexed keywords

PALIVIZUMAB; RIBAVIRIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT REJECTION; HOSPITALIZATION; HUMAN; INCIDENCE; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS CULTURE; VIRUS INFECTION;

ADULT; ANTIVIRAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INCIDENCE; LUNG; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 77349096434     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.08.012     Document Type: Article

References (46)

1. Milstone A.P., Brumble L.M., Barnes J., et al. A single-season prospective study of respiratory viral infections in lung transplant recipients. Eur Respir J 28 (2006) 131-137
2. Wendt C.H. Community respiratory viruses: organ transplant recipients. Am J Med 102 (1997) 31-36
3. Chakinala M.M., and Walter M.J. Community acquired respiratory viral infections after lung transplantation: clinical features and long-term consequences. Semin Thorac Cardiovasc Surg 16 (2004) 342-349
4. Community-acquired respiratory viruses. Am J Transplant 4 (2004) 105-109
5. McCurdy L.H., Milstone A., and Dummer S. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin. J Heart Lung Transplant 22 (2003) 745-753
6. Palmer S.M., Henshaw N.G., Howell D.N., et al. Community respiratory viral infection in adult lung transplant recipients. Chest 113 (1998) 944-950
7. Glanville A.R., Scott A.I., Morton J.M., et al. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant 24 (2005) 2114-2119
8. Peck A.J., Englund J.A., Kuypers J., et al. Respiratory virus infection among hematopoietic cell transplantation recipients: evidence for asymptomatic parainfluenza virus infection. Blood 110 (2007) 1681-1688
9. Boeckh M., Englund J., Li Y., et al. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis 44 (2007) 245-249
10. Adams R.H. Preemptive treatment of pediatric bone marrow transplant patients with asymptomatic respiratory syncytial virus infection with aerosolized ribavirin. Biol Blood Marrow Transplant 7 (2001) 16-18
11. Ljungman P., Ward K.N., Crooks B.N., et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 28 (2001) 479-484
12. Whimbey E., Champlin R.E., Couch R.B., et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 22 (1996) 778-782
13. Englund J.A., and Whimbey E.E. Community-acquired respiratory viruses after hemopoietic stem cell or solid organ transplantation. In: Bowden R.A., Ljungman P., and Paya C.V. (Eds). Transplant infections. 2nd ed. (2003), Lippincott, Williams and Wilkins, Philadelphia 375-398
14. Ghosh S., Champlin R.E., Englund J., et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 25 (2000) 751-755
15. Van Kraaij M.G., van Elden L.J., van Loon A.M., et al. Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture. Clin Infect Dis 40 (2005) 662-669
16. Cortez K., Murphy B.R., Almeida K.N., et al. Immune-globulin prophylaxis of respiratory syncytial virus infection in patients undergoing stem-cell transplantation. J Infect Dis 186 (2002) 834-838 15
17. Chakrabarti S., Collingham K.E., Holder K., et al. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study. Bone Marrow Transplant 28 (2001) 759-763
18. Krinzman S., Basşgöz N., Kradin R., et al. Respiratory syncytial virus-associated infections in adult recipients of solid organ transplants. J Heart Lung Transplant 17 (1998) 202-210
19. Swedish Consensus Group. Management of infections caused by respiratory syncytial virus. Scand J Infect Dis 33 (2001) 323-328
20. Hirsch H., Widmer A., and Francioli P. Respiratorisches Syncytial-Virus (RSV) Infektion: Massnahmen beim immunsupprimierten Patienten. Swiss-NOSO Bulletin 11 (2004) 17-21
21. Garbino J., Gerbase M.W., Wunderli W., et al. Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact. Am J Respir Crit Care Med 170 (2004) 1197-1203
22. Garbino J., Crespo S., Aubert J.D., et al. A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (non-SARS)-related human coronavirus infection. Clin Infect Dis 43 (2006) 1009-1015
23. Weinberg A., Zamora M.R., Li S., et al. The value of polymerase chain reaction for the diagnosis of viral respiratory tract infections in lung transplant recipients. J Clin Virol 25 (2002) 171-175
24. Dewhurst-Maridor G., Simonet V., Bornand J.E., et al. Development of a quantitative TaqMan RT-PCR for respiratory syncytial virus. J Virol Methods 120 (2004) 41-49
25. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection. J Heart Lung Transplant 15 (1996) 1-15
26. Ko J.P., Shepard J.A., Sproule M.W., et al. CT manifestations of respiratory syncytial virus infection in lung transplant recipients. J Comput Assist Tomogr 24 (2000) 235-241
27. Matar L.D., McAdams H.P., Palmer S.M., et al. Respiratory viral infections in lung transplant recipients: radiologic findings with clinical correlation. Radiology 213 (1999) 735-742
28. Holt N.D., Gould F.K., Taylor C.E., et al. Incidence and significance of noncytomegalovirus viral respiratory infection after adult lung transplantation. J Heart Lung Transplant 16 (1997) 416-419
29. Khalifah A.P., Hachem R.R., Chakinala M.M., et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 170 (2004) 181-187
30. Billings J.L., Hertz M.I., Savik K., et al. Respiratory viruses and chronic rejection in lung transplant recipients. J Heart Lung Transplant 21 (2002) 559-566
31. Tcheurekdjian H., Martin J., Kobayashi R., et al. Intrainfusion and postinfusion adverse events related to intravenous immunoglobulin therapy in immunodeficiency states. Allergy Asthma Proc 27 (2006) 532-536
32. Aghamohammadi A., Farhoudi A., Nikzad M., et al. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Ann Allergy Asthma Immunol 92 (2004) 60-64
33. Janai H.K., Marks M.I., Zaleska M., et al. Ribavirin: adverse drug reactions, 1986 to 1988. Pediatr Infect Dis J 9 (1990) 209-211
34. Boeckh M., Berrey M.M., Bowden R.A., et al. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. J Infect Dis 184 (2001) 350-354
35. Kusuda S., Koizumi T., Sakai T., et al. Results of clinical surveillance during the Japanese first palivizumab season in 2002-2003. Pediatr Int 48 (2006) 362-368
36. Knowles S.R., Phillips E.J., Dresser L., et al. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clin Infect Dis 37 (2003) 1139-1142
37. Pelaez A., Lyon G.M., Force S.D., et al. Efficacy of oral ribavirin in lung transplant recipients with respiratory syncytial virus lower respiratory tract infection. J Heart Lung Transplant 28 (2009) 67-71
38. Lofland J.H., O'Connor J.P., Chatterton M.L., et al. Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis. Clin Ther 22 (2000) 1357-1369
39. Nuijten M.J., Wittenberg W., and Lebmeier M. Cost effectiveness of palivizumab for respiratory syncytial virus prophylaxis in high-risk children: a UK analysis. Pharmacoeconomics 25 (2007) 55-71
40. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 112 (2003) 1442-1446
41. Pohl C., Green M., Wald E.R., et al. Respiratory syncytial virus infections in pediatric liver transplant recipients. J Infect Dis 165 (1992) 166-169
42. Englund J.A., Piedra P.A., and Whimbey E. Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients. Am J Med 102 (1997) 61-70
43. Allen M.D., Burke C.M., McGregor C.G., et al. Steroid-responsive bronchiolitis after human heart-lung transplantation. J Thorac Cardiovasc Surg 92 (1986) 449-451
44. Doud J.R., Hinkamp T., and Garrity E.R. Respiratory syncytial virus pneumonia in a lung transplant recipient. J Heart Lung Transplant 11 (1992) 77-79
45. Murris-Espin M., Didier A., Carre P., et al. Continuous aerosolised ribavirin for respiratory syncytial virus infection in lung transplant recipients. Lancet 341 (1993) 897
46. Wendt C.H., Fox J.M., and Hertz M.I. Paramyxovirus infection in lung transplant recipients. J Heart Lung Transplant 14 (1995) 479-485